These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2744781)

  • 1. Pharmacokinetic interaction between indoramin and ethanol.
    Abrams SM; Pierce DM; Johnston A; Hedges A; Franklin RA; Turner P
    Hum Toxicol; 1989 May; 8(3):237-41. PubMed ID: 2744781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of oral indoramin during pregnancy.
    Schabort I; Odendaal HJ; Pierce DM
    Br J Clin Pharmacol; 1990 Apr; 29(4):397-401. PubMed ID: 2328193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the clinical pharmacokinetics and metabolism of the alpha 1-adrenoceptor antagonist indoramin.
    Pierce DM
    Xenobiotica; 1990 Dec; 20(12):1357-67. PubMed ID: 1981634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and systemic availability of the antihypertensive agent indoramin and its metabolite 6-hydroxyindoramin in healthy subjects.
    Pierce DM; Abrams SM; Franklin RA
    Eur J Clin Pharmacol; 1987; 32(6):619-23. PubMed ID: 3653231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of indoramin and its 6-hydroxylated metabolite after repeated oral dosing.
    Pierce DM; Warrington SJ; Franklin RA
    Biopharm Drug Dispos; 1988; 9(2):147-57. PubMed ID: 2897212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in the pharmacology and pharmacokinetics of indoramin.
    Archibald JL
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S16-9. PubMed ID: 2423790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra- and inter-subject variation in the pharmacokinetics of indoramin and its 6-hydroxylated metabolite.
    Pierce DM; Abrams SM; Franklin RA
    Eur J Clin Pharmacol; 1988; 35(2):195-8. PubMed ID: 3191938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of indoramin in man.
    Draffan GH; Lewis PJ; Firmin JL; Jordan TW; Dollery CT
    Br J Clin Pharmacol; 1976 Jun; 3(3):489-95. PubMed ID: 788751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of indoramin and 6-hydroxyindoramin in poor and extensive hydroxylators of debrisoquine.
    Pierce DM; Smith SE; Franklin RA
    Eur J Clin Pharmacol; 1987; 33(1):59-65. PubMed ID: 3691597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of oral indoramin.
    Volans GN; Jeffereys D; Latham AN; Frost T
    Curr Med Res Opin; 1982; 8(1):51-3. PubMed ID: 7105823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acute and chronic indoramin administration on baroreflex function and tremor in humans.
    Deering AH; Riddell JG; Harron DW; Shanks RG
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):284-90. PubMed ID: 2452920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of indoramin and its metabolite 6-hydroxyindoramin after single and multiple doses to cirrhotic liver patients.
    Neumann G; Wilke G; Reimold WV; Pierce DM; Giesing M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S20-4. PubMed ID: 2423791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential blockade of alpha-adrenoceptors by indoramin.
    Nicholls DP; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
    Br J Clin Pharmacol; 1984 Jun; 17(6):719-28. PubMed ID: 6146328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intravenous indoramin in middle-aged male and female volunteers.
    Norbury HM; Franklin RA; Marrott PK; Warrington SJ
    Eur J Clin Pharmacol; 1983; 25(2):243-6. PubMed ID: 6628508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of oral indoramin in elderly and middle-aged female volunteers.
    Norbury HM; Franklin RA; Marrott PK; Warrington SJ
    Eur J Clin Pharmacol; 1984; 27(2):247-9. PubMed ID: 6499905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute and chronic effects of indoramin on renal function, hemodynamics, and transport.
    Morrison G; Spar B; Walker BR; Goldfarb S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S25-9. PubMed ID: 2423792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.
    Pierce V; Shepperson NB; Todd MH; Waterfall JF
    Br J Pharmacol; 1986 Feb; 87(2):433-41. PubMed ID: 3955309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.
    Nicholls DP; McNeill J; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
    Br J Clin Pharmacol; 1984 Aug; 18(2):215-21. PubMed ID: 6386022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of intravenous indoramin hydrochloride in man.
    Coleman AJ; Leary WP; Asmal AC
    J Int Med Res; 1979; 7(6):511-8. PubMed ID: 520654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.
    Holmes B; Sorkin EM
    Drugs; 1986 Jun; 31(6):467-99. PubMed ID: 3525084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.